Revelation Biosciences In... (REVB)
NASDAQ: REVB
· Real-Time Price · USD
0.80
0.01 (0.76%)
At close: Jun 16, 2025, 3:58 PM
0.80
0.60%
Pre-market: Jun 17, 2025, 04:52 AM EDT
0.76% (1D)
| Bid | 0.8 |
| Market Cap | 1.62M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -14.41M |
| EPS (ttm) | -82.07 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.41 |
| Analyst | n/a |
| Ask | 0.9 |
| Volume | 231,504 |
| Avg. Volume (20D) | 1,022,811 |
| Open | 0.79 |
| Previous Close | 0.79 |
| Day's Range | 0.79 - 0.81 |
| 52-Week Range | 0.77 - 60.80 |
| Beta | -0.09 |
About REVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol REVB
Website n/a
2 weeks ago
-54.4%
Revelation Biosciences shares are trading lower af...
Unlock content with
Pro Subscription
4 months ago
-23.84%
Revelation Biosciences shares are trading lower after the company announced plans for a 1-for-16 reverse stock split.
3 months ago · businesswire.com
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear CellsSAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammati...